Search - Prime Therapeutics
Navigate to
-
In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
Perspectives High-Cost Therapy Profile: January Detailed information about Atidarsagene Autotemcel Intravenous (IV) High Cost Therapy Profile Atidarsagene Autotemcel Intravenous (IV) Orchard ...
-
More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer
Prime Article: Stories -
Journal of Managed Care & Specialty Pharmacy (JMCP)
PA Sub-Categories: GLP-1 Prime Article: In the News -
A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.
Prime Article: Stories -
Read Clinical News: June 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics MDMA-ASSISTED THERAPY FOR PTSD...
-
Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings
PA Sub-Categories: GLP-1 Awards Specialty drugs Prime Article: Stories -
Identifying and managing diabetes and weight loss therapies earns AMCP platinum award
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
Publications Clinical Highlights: March 2025 Your monthly source for drug information highlights. March 27, 2025 Trending topics As of late February 2025, the United States (U.S.) Centers for...
-
This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Read Drug Approvals Monthly Update: January 2024 Critical updates in an ever-changing environment. Drug Approval Update Specialty New drugs 12/22/2023 Wainua™ (eplontersen) The United States (U.S.)...
-
Read Drug Approvals Monthly Update: February 2024 This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news...
-
Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Events -
publications Spring 2024 Prime Therapeutics Report March 15, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6)...
-
13th annual report the preeminent source for medical benefit drug trend
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Managed Healthcare Executive
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...
-
publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...